Your browser doesn't support javascript.
loading
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy.
Locati, L D; Piovesan, A; Durante, C; Bregni, M; Castagna, M G; Zovato, S; Giusti, M; Ibrahim, T; Puxeddu, E; Fedele, G; Pellegriti, G; Rinaldi, G; Giuffrida, D; Verderame, F; Bertolini, F; Bergamini, C; Nervo, A; Grani, G; Rizzati, S; Morelli, S; Puliafito, I; Elisei, R.
Afiliação
  • Locati LD; Head and Neck Medical Oncology; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: laura.locati@istitutotumori.mi.it.
  • Piovesan A; Dept. Oncology, Oncological Endocrinology, A.O.U. Città della Salute e della Scienza, Ospedale Molinette, Torino, Italy. Electronic address: apiovesan@cittadellasalute.to.it.
  • Durante C; Dept Internal Medicine and Medical Specialties, Policlinico Umberto I, Roma, Italy. Electronic address: cosimo.durante@uniroma1.it.
  • Bregni M; Dept Medical Oncology, Ospedale Busto Arsizio-ASST Valle Olona, Busto Arsizio, Italy. Electronic address: mbregni@aobusto.it.
  • Castagna MG; Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy. Electronic address: m.g.castagna@ao-siena.toscana.it.
  • Zovato S; Familial Cancer Clinic and Oncoendocrinology Veneto Institute of Oncology IOV- IRCCS, Padua, Italy. Electronic address: stefania.zovato@ioveneto.it.
  • Giusti M; Dept Internal Medicine and Medical Specialties, Clinical Endocrinology, IRCCS San Martino Hospital, Genova, Italy. Electronic address: magius@unige.it.
  • Ibrahim T; Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. Electronic address: toni.ibrahim@irst.emr.it.
  • Puxeddu E; Department of Medicine, University of Perugia, Perugia, Italy.
  • Fedele G; High Research Srl, Milano, Italy. Electronic address: guido.fedele@fastwebnet.it.
  • Pellegriti G; Endocrinology Division, Garibaldi Nesima Hospital, Catania, Italy. Electronic address: g.pellegriti@unict.it.
  • Rinaldi G; Dept Surgical and Oncological Sciences, Policlinico Paolo Giaccone, Palermo, Italy. Electronic address: taniarinaldi02@gmail.com.
  • Giuffrida D; Dept Medical Oncology, Istituto Oncologico del Mediterraneo, Viagrande, Italy. Electronic address: giuffridadario@alice.it.
  • Verderame F; Dept Hematology and Oncology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy. Electronic address: f.verderame@villasofia.it.
  • Bertolini F; Dept Oncology and Haematology, Modena University Hospital, Modena, Italy. Electronic address: bertolini.federica@policlinico.mo.it.
  • Bergamini C; Head and Neck Medical Oncology; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: cristiana.bergamini@istitutotumori.mi.it.
  • Nervo A; Dept. Oncology, Oncological Endocrinology, A.O.U. Città della Salute e della Scienza, Ospedale Molinette, Torino, Italy. Electronic address: alice.nervo@cittadellasalute.to.it.
  • Grani G; Dept Internal Medicine and Medical Specialties, Policlinico Umberto I, Roma, Italy. Electronic address: giorgio.grani@uniroma1.it.
  • Rizzati S; Familial Cancer Clinic and Oncoendocrinology Veneto Institute of Oncology IOV- IRCCS, Padua, Italy. Electronic address: silvia.rizzati@ioveneto.it.
  • Morelli S; Department of Medicine, University of Perugia, Perugia, Italy. Electronic address: silvia.morelli@unipg.it.
  • Puliafito I; Dept Medical Oncology, Istituto Oncologico del Mediterraneo, Viagrande, Italy. Electronic address: dott.ssapuliafito@gmail.com.
  • Elisei R; Dept Clinical and Experimental Medicine, A.O Universitaria Pisana, Pisa, Italy. Electronic address: rossella.elisei@med.unipi.it.
Eur J Cancer ; 118: 35-40, 2019 09.
Article em En | MEDLINE | ID: mdl-31299580

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Tolerância a Radiação / Neoplasias da Glândula Tireoide / Compostos Radiofarmacêuticos / Inibidores de Proteínas Quinases / Radioisótopos do Iodo / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Tolerância a Radiação / Neoplasias da Glândula Tireoide / Compostos Radiofarmacêuticos / Inibidores de Proteínas Quinases / Radioisótopos do Iodo / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article